MENS — Jyong Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- $131.39m
- $148.66m
Annual cashflow statement for Jyong Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.2 | -6.63 | -4.4 | -3.02 | -4.67 |
| Depreciation | |||||
| Non-Cash Items | 0.849 | 0.599 | 0.554 | 0.761 | -19.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.24 | 2.94 | 1.12 | -1.49 | 20.7 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.98 | -2.97 | -2.6 | -3.62 | -3.04 |
| Capital Expenditures | -0.137 | -0.246 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.17 | 1.64 | 0.095 | 0 | -13.5 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.31 | 1.39 | 0.095 | 0 | -13.5 |
| Financing Cash Flow Items | -0.035 | -0.276 | -0.445 | -0.213 | -0.114 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.38 | 3.33 | 2.03 | 1.99 | 17.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.61 | 1.72 | -0.532 | -1.64 | 1.08 |